{
  "cik": 1817713,
  "cik_padded": "0001817713",
  "entityName": "Janux Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-076918",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1043000.0,
        "cash": 52334000.0,
        "eps_diluted": -1.83,
        "free_cash_flow": -83278000.0,
        "net_income": -113625000.0,
        "operating_cash_flow": -82235000.0,
        "operating_income": -157667000.0,
        "revenue": 10000000.0,
        "stockholders_equity": 956822000.0,
        "total_assets": 1001565000.0,
        "total_liabilities": 44743000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.04676209368095633,
        "revenue_growth_yoy": -0.055534567434831886,
        "roa_avg2y": -0.11015078903833635,
        "roa_period_end": -0.11344745473334232,
        "roe_avg2y": -0.11479574439925581,
        "roe_period_end": -0.11875249523944893
      }
    },
    {
      "accn": "0001193125-26-076918",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 359000.0,
        "cash": 430605000.0,
        "eps_diluted": -1.28,
        "free_cash_flow": -44173000.0,
        "net_income": -68994000.0,
        "operating_cash_flow": -43814000.0,
        "operating_income": -98847000.0,
        "revenue": 10588000.0,
        "stockholders_equity": 1022781000.0,
        "total_assets": 1061516000.0,
        "total_liabilities": 38735000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.03787223266759942,
        "revenue_growth_yoy": 0.30990968699740196,
        "roa_avg2y": -0.09569720435834646,
        "roa_period_end": -0.06499572309790903,
        "roe_avg2y": -0.10093261065151082,
        "roe_period_end": -0.0674572562454719
      }
    },
    {
      "accn": "0001193125-26-076918",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1850000.0,
        "cash": 19205000.0,
        "eps_diluted": -1.32,
        "free_cash_flow": -52425000.0,
        "net_income": -58293000.0,
        "operating_cash_flow": -50575000.0,
        "operating_income": -72979000.0,
        "revenue": 8083000.0,
        "stockholders_equity": 344349000.0,
        "total_assets": 380407000.0,
        "total_liabilities": 36058000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1047135319109392,
        "revenue_growth_yoy": -0.06142591732466326,
        "roa_avg2y": -0.15661383337564833,
        "roa_period_end": -0.15323850507482775,
        "roe_avg2y": -0.17529383285545244,
        "roe_period_end": -0.16928465016596533
      }
    },
    {
      "accn": "0001193125-26-076918",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 6445000.0,
        "cash": 51426000.0,
        "eps_diluted": -1.52,
        "free_cash_flow": -49367000.0,
        "net_income": -63059000.0,
        "operating_cash_flow": -42922000.0,
        "operating_income": -67091000.0,
        "revenue": 8612000.0,
        "stockholders_equity": 320740000.0,
        "total_assets": 364010000.0,
        "total_liabilities": 43270000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.13490677807569995,
        "revenue_growth_yoy": 1.367885620016497,
        "roa_avg2y": -0.16955127084806557,
        "roa_period_end": -0.17323425180626906,
        "roe_avg2y": -0.18355997304484134,
        "roe_period_end": -0.19660472656980732
      }
    },
    {
      "accn": "0000950170-25-029177",
      "filed": "2025-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1482000.0,
        "cash": 35582000.0,
        "eps_diluted": -1.39,
        "free_cash_flow": -18458000.0,
        "net_income": -32672000.0,
        "operating_cash_flow": -16976000.0,
        "operating_income": -32929000.0,
        "revenue": 3637000.0,
        "stockholders_equity": 366327000.0,
        "total_assets": 379824000.0,
        "total_liabilities": 13497000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.036844131063230395,
        "roa_avg2y": -0.16499301839961014,
        "roa_period_end": -0.08601878764901638,
        "roe_avg2y": -0.1858005226208383,
        "roe_period_end": -0.08918807513505693
      }
    },
    {
      "accn": "0000950170-23-007311",
      "filed": "2023-03-10",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 0.0,
        "cash": 7813000.0,
        "free_cash_flow": -4369000.0,
        "net_income": -6784000.0,
        "operating_cash_flow": -4369000.0,
        "operating_income": -4843000.0,
        "stockholders_equity": -14638000.0,
        "total_assets": 16217000.0,
        "total_liabilities": 9231000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.4183264475550349,
        "roe_avg2y": 0.6008325214772828
      }
    },
    {
      "accn": "0000950170-22-004171",
      "filed": "2022-03-18",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -7944000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-076918",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001817713.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001817713.json"
  },
  "ticker": "JANX"
}